References
- Bai X, Scheutz F, Dahlgren HM, Hedenström I, Jernberg C. Characterization of clinical Escherichia coli strains producing a novel Shiga toxin 2 subtype in Sweden and Denmark. Microorganisms. 2021 Nov;9(11):2374. https://doi.org/10.3390/microorganisms9112374
- Bibbal D, Ruiz P, Sapountzis P, Mazuy-Cruchaudet C, Loukiadis E, Auvray F, Forano E, Brugère H. Persistent circulation of entero-hemorrhagic Escherichia coli (EHEC) O157:H7 in cattle farms: Characterization of enterohemorrhagic Escherichia coli O157:H7 strains and fecal microbial communities of bovine shedders and non-shedders. Front Vet Sci. 2022 Mar;9:852475. https://doi.org/10.3389/fvets.2022.852475
- Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, Bauwens A, Peters G, Karch H. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: A microbiological study. Lancet Infect Dis. 2011 Sep;11(9):671–676. https://doi.org/10.1016/S1473-3099(11)70165-7
- Bitzan M. Treatment options for HUS secondary to Escherichia coli O157:H7. Kidney Int Suppl. 2009 Feb;(112):62–66. https://doi.org/10.1038/ki.2008.624
- Bouzari S, Farhang E, Hosseini SM, Alikhani MY. Prevalence and antimicrobial resistance of shiga toxin-producing Escherichia coli and enteropathogenic Escherichia coli isolated from patients with acute diarrhea. Iran J Microbiol. 2018 Jun;10(3):151–157.
- Chen ML, Hao Z, Tian Y, Zhang QY, Gao PJ, Jin JL. Different effects of six antibiotics and ten traditional Chinese medicines on Shiga toxin expression by Escherichia coli O157:H7. Evid Based Complement Alternat Med. 2013;2013:121407. https://doi.org/10.1155/2013/121407
- Contreras CA, Ochoa TJ, Ruiz J, Lacher DW, Rivera FP, Saenz Y, Chea-Woo E, Zavaleta N, Gil AI, Lanata CF, et al. Phylogenetic relationships of Shiga toxin-producing Escherichia coli isolated from Peruvian children. J Med Microbiol. 2011 May;60(Pt_5):639–646. https://doi.org/10.1099/jmm.0.026666-0
- ECDC. STEC infection. In: ECDC. Annual epidemiological report for 2021. Stockholm (Sweden): European Centre for Disease Prevention and Control; 2022 [cited 2023 Oct 30]. Available from https://www.ecdc.europa.eu/sites/default/files/documents/AER%20STEC%20-%202021.pdf
- EUCAST. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 12.0. Basel (Switzerland): The European Committee on Antimicrobial Susceptibility Testing; 2022.
- Fatima R, Aziz M. Enterohemorrhagic Escherichia coli. [Internet, updated 2023 Jun 26]. Treasure Island (USA): StatPearls Publishing; 2023 [cited 2023 Oct 30]. Available from https://www.ncbi.nlm.nih.gov/books/NBK519509
- Harkins VJ, McAllister DA, Reynolds BC. Shiga-toxin E. coli Hemolytic Uremic Syndrome: Review of management and longterm outcome. Curr Pediatr Rep. 2020;8:16–25. https://doi.org/10.1007/s40124-020-00208-7
- Hermos CR, Janineh M, Han LL, McAdam AJ. Shiga toxin-producing Escherichia coli in children: Diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection. J Clin Microbiol. 2011 Mar;49(3):955–959. https://doi.org/10.1128/jcm.02119-10
- Herold S, Karch H, Schmidt H. Shiga toxin-encoding bacteriophages – genomes in motion. Int J Med Microbiol. 2004 Sep; 294 (2–3):115–121. https://doi.org/10.1016/j.ijmm.2004.06.023
- Hua Y, Chromek M, Frykman A, Jernberg C, Georgieva V, Hansson S, Zhang J, Marits AK, Wan C, Matussek A, et al. Wholegenome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden. Virulence. 2021 Dec;12(1):1296–1305. https://doi.org/10.1080/21505594.2021.1922010
- Januszkiewicz A, Rastawicki W. Molecular characterization of Shiga toxin-producing Escherichia coli strains isolated in Poland. Pol J Microbiol. 2016 Aug;65(3):261–269. https://doi.org/10.5604/17331331.1215601
- Jenssen GR, Hovland E, Bjerre A, Bangstad HJ, Nygard K, Vold L. Incidence and etiology of hemolytic-uremic syndrome in children in Norway, 1999-2008 – A retrospective study of hospital records to assess the sensitivity of surveillance. BMC Infect Dis. 2014 May; 14:265. https://doi.org/10.1186/1471-2334-14-265
- Kagkli DM, Weber TP, Van den Bulcke M, Folloni S, Tozzoli R, Morabito S, Ermolli M, Gribaldo L, Van den Eede G. Application of the modular approach to an in-house validation study of realtime PCR methods for the detection and serogroup determination of verocytotoxigenic Escherichia coli. Appl Environ Microbiol. 2011 Oct;77(19):6954–6963. https://doi.org/10.1128/aem.05357-11
- Kawamori F, Hiroi M, Harada T, Ohata K, Sugiyama K, Masuda T, Ohashi N. Molecular typing of Japanese Escherichia coli O157: H7 isolates from clinical specimens by multilocus variable-number tandem repeat analysis and PFGE. J Med Microbiol. 2008 Jan; 57(Pt_1): 58–63. https://doi.org/10.1099/jmm.0.47213-0
- Kikuchi K, Lee K, Ueno H, Tomari K, Kobori S, Kaetsu A, Matsui M, Suzuki S, Sekizuka T, Kuroda M, et al. Enterohaemorrhagic Escherichia coli O121:H19 acquired an extended-spectrum β-lactamase gene during the development of an outbreak in two nurseries. Microb Genom. 2019 Jul;5(7):e000278. https://doi.org/10.1099/mgen.0.000278
- Koyanagi Y, Suzuki R, Ihara K, Miyagi H, Isogai H, Yoneyama H, Isogai E. Intestinal Clostridium species lower host susceptibility to enterohemorrhagic Escherichia coli O157:H7 infection. Pathog Dis. 2019 Jun;77(4):ftz036. https://doi.org/10.1093/femspd/ftz036
- Kurabayashi K, Tanimoto K, Fueki S, Tomita H, Hirakawa H. Elevated expression of GlpT and UhpT via FNR activation contributes to increased fosfomycin susceptibility in Escherichia coli under anaerobic conditions. Antimicrob Agents Chemother. 2015 Oct;59(10):6352–6360. https://doi.org/10.1128/aac.01176-15
- Matussek A, Mernelius S, Chromek M, Zhang J, Frykman A, Hansson S, Georgieva V, Xiong Y, Bai X. Genome-wide association study of hemolytic uremic syndrome causing Shiga toxin-producing Escherichia coli from Sweden, 1994-2018. Eur J Clin Microbiol Infect Dis. 2023 Jun;42(6):771–779. https://doi.org/10.1007/s10096-023-04600-1
- Mele C, Remuzzi G, Noris M. Hemolytic uremic syndrome. Semin Immunopathol. 2014 Jul;36(4):399–420. https://doi.org/10.1007/s00281-014-0416-x
- Mühlen S, Dersch P. Treatment strategies for infections with Shiga toxin-producing Escherichia coli. Front Cell Infect Microbiol. 2020 May;10:169. https://doi.org/10.3389/fcimb.2020.00169
- Nielsen EM, Andersen MT. Detection and characterization of verocytotoxin-producing Escherichia coli by automated 5’ nuclease PCR assay. J Clin Microbiol. 2003 Jul;41(7):2884–2893. https://doi.org/10.1128/jcm.41.7.2884-2893.2003
- Nitschke M, Sayk F, Härtel C, Roseland RT, Hauswaldt S, Steinhoff J, Fellermann K, Derad I, Wellhöner P, Büning J, et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA. 2012 Mar;307(10):1046–1052. https://doi.org/10.1001/jama.2012.264
- Noris M, Bresin E, Mele C, Remuzzi G. Genetic atypical hemolytic uremic syndrome. [Internet, update 2021 Sep 23]. In: Adam MP, Mirzaa GM, Pagon RA et al., editors. GeneReviews®. Seattle (USA): University of Washington; 1993-2023 [cited 2023 Nov 30]. Available from https://www.ncbi.nlm.nih.gov/books/NBK1367/
- Perelle S, Dilasser F, Grout J, Fach P. Detection by 5’-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world’s most frequent clinical cases. Mol Cell Probes. 2004 Jun;18(3):185–192. https://doi.org/10.1016/j.mcp.2003.12.004
- Perelle S, Dilasser F, Grout J, Fach P. Detection of Escherichia coli serogroup O103 by real-time polymerase chain reaction. J Appl Microbiol. 2005;98(5): 1162–1168. https://doi.org/10.1111/j.1365-2672.2005.02545.x
- Prado V, Basualdo W, Arellano C, Martínez J, Levine MM. [In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials. Relationship between antibiotic resistance and toxigenic genotype] (in Spanish). Rev Med Chil. 1995 Sep;123(9): 1085–1090.
- Rastawicki W, Śmietańska K, Rokosz-Chudziak N, Wolkowicz T. Antibody response to lipopolysaccharides and recombinant proteins of Shiga toxin (STX)-producing Escherichia coli (STEC) in children with haemolytic uraemic syndrome in Poland. Lett Appl Microbiol. 2020 Jun;70(6):440–446. https://doi.org/10.1111/lam.13295
- Sallée M, Ismail K, Fakhouri F, Vacher-Coponat H, Moussi-Francés J, Frémaux-Bacchi V, Burtey S. Thrombocytopenia is not mandatory to diagnose haemolytic and uremic syndrome. BMC Nephrol. 2013 Jan;14:3. https://doi.org/10.1186/1471-2369-14-3
- Skinner C, Zhang G, Patfield S, He X. An in vitro combined antibiotic-antibody treatment eliminates toxicity from Shiga toxinproducing Escherichia coli. Antimicrob Agents Chemother. 2015 Sep; 59(9):5435–5444. https://doi.org/10.1128/aac.00763-15
- Tarr GAM, Oltean HN, Phipps AI, Rabinowitz P, Tarr PI. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition. Int J Med Microbiol. 2018 Oct;308(7):921–926. https://doi.org/10.1016/j.ijmm.2018.06.009
- The Institut Pasteur. Enterohemorrhagic Escherichia coli (EHEC) [Internet]. Paris (France): Institut Pasteur; 2023 [cited 2023 Oct 30]. Available from https://www.pasteur.fr/en/medical-center/disease-sheets/enterohemorrhagic-escherichia-coli-ehec
- WHO. E. coli. [Internet]. Geneva (Switzerland): World Health Organization; 2018 [cited 2023 Oct 30]. Available from https://www.who.int/news-room/fact-sheets/detail/e-coli
- Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: A multivariable analysis. Clin Infect Dis. 2012 Jul;55(1):33–41. https://doi.org/10.1093/cid/cis299
- Yoshii N, Ogura Y, Hayashi T, Ajiro T, Sameshima T, Nakazawa M, Kusumoto M, Iwata T, Akiba M. Pulsed-field gel electrophoresis profile changes resulting from spontaneous chromosomal deletions in enterohemorrhagic Escherichia coli O157:H7 during passage in cattle. Appl Environ Microbiol. 2009 Sep;75(17):5719–5726. https://doi.org/10.1128/aem.00558-09
- Zhu W, Guo H, Xu J, Wu W, Yi Y, Wang J, Duan R, Tong J, Du Y. Enterohemorrhagic Escherichia coli O157:H7 – Xuzhou City, Jiangsu Province, China, 2001–2021. China CDC Wkly. 2023 Apr;5(14): 311–314. https://doi.org/10.46234/ccdcw2023.057